Figures and Tables

From the following article:

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

Andreas Diefenbach, Eric R. Jensen, Amanda M. Jamieson and David H. Raulet

Nature 413, 165-171(13 September 2001)

doi:10.1038/35093109

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

EL4 and B16-BL6 tumour cells that express NKG2D ligands are rejected by NK cells in syngeneic mice.

Full size figure and legend (92K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

RMA cells expressing NKG2D ligands are rejected by NK cells and CD8 T cells in syngeneic mice.

Full size figure and legend (63K)
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 3

Vaccination with ligand-expressing tumour cells confers specific immunity to the corresponding ligand-negative tumour cells.

Full size figure and legend (84K)
Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 4

CTL responses primed by irradiated ligand-transduced RMA cells.

Full size figure and legend (52K)
Figure 5 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 5

RMA cells expressing NKG2D ligands stimulate NK cell recruitment and activation in vivo.

Full size figure and legend (40K)
BACK TO ARTICLE